SCHEMBL31649212

SCHEMBL31649212

CCCCOC(=O)N[C@H](CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)C(=O)N1CCC[C@H]2CCCC[C@@H]21

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 3/20 0.47
▸ ACE2 Q9BYF1 2/20 0.47
▸ ELANE P08246 1/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ITGB3 P05106 2/20 0.36
▸ ITGA2B P08514 2/20 0.36
▸ DPP4 P27487 2/20 0.35
▸ DPP8 Q6V1X1 2/20 0.35
▸ PREP P48147 3/20 0.35
▸ BCHE P06276 2/20 0.35
▸ ACHE P22303 2/20 0.35
▸ DPP7 Q9UHL4 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ FKBP1A P62942 2/20 0.35
▸ FAP Q12884 1/20 0.34
▸ P2RY12 Q9H244 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31649055 0.87 ACE (0.46) ACEELANENPC1RAB9ASMN1; SMN2
SCHEMBL31649231 0.80 ACE (0.45) ACEELANENPC1RAB9ASMN1; SMN2
SCHEMBL31649025 0.79 DPP7 (0.41) NPC1RAB9ASMN1; SMN2DPP4DPP8
SCHEMBL3822519 0.79 SMN1; SMN2 (0.42) ACEACE2NPC1RAB9ASMN1; SMN2
SCHEMBL31649210 0.79 ACE (0.47) ACEACE2ELANENPC1RAB9A
SCHEMBL31649181 0.76 ACE (0.47) ACEACE2ELANENPC1RAB9A
SCHEMBL31649328 0.76 TACR1 (0.42) DPP7ALDH1A1
SCHEMBL31649422 0.76 DPP7 (0.45) ACENPC1RAB9ASMN1; SMN2DPP4
SCHEMBL31649445 0.76 ACE (0.46) ACEACE2ELANENPC1RAB9A
SCHEMBL31649228 0.76 ACE (0.45) ACEACE2ELANENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132943-A1 DECAHYDROQUINOLINES AS DNA POLYMERASE THETA INHIBITORS BREAKPOINT THERAPEUTICS GMBH (DE) 2025-06-26 — — WO disclosed
Send feedback